Donate
Member Login
Mobile Buttons
Donate
Member Login
About Us
About ANZCHOG
Board of Directors
Our People
Membership
Supporters & Partners
Why childhood cancer is different
Collaborations
Equitable Pathways
Resources
Clinical Trials & Research
Clinical Trials
Research
ANZCHOG Children’s Cancer Clinical Trials Repository
CIRCAA
Annual Scientific Meeting
News & Events
News
Events
Position Statements & Guidelines
Contact Us
Last Updated | 31 March 2026
BIOMEDE
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
External Registry
Site Status
Perth Children's Hospital
Monash Health Clayton Royal Children's Hospital Starship Children's Hospital
Queensland Children's Hospital
(QLD)
John Hunter Children's Hospital
(NSW)
Sydney Children's Hospital
(NSW)
Monash Health Clayton
(VIC)
Royal Children's Hospital
(VIC)
Women's and Children's Hospital
(SA)
Perth Children's Hospital
(WA)
Royal Hobart Hospital
(TAS)
Children's Hospital at Westmead
(NSW)
Starship Children's Hospital
(NZ)
Christchurch Hospital
(NZ)
Preparing to Open
Open
Temporarily Closed
Closed
Complete
Adult Sites
These sites are not monitored. Status may vary.
Diagnosis Stage
Newly diagnosed
National Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Open Date
31/07/2018
Conditions
Diffuse Intrinsic Pontine Glioma (DIPG)
Patient Range
6 months
–
25 years
0
50
99+
Disease Type
Brain and Spinal (Central Nervous System) Tumours
Study Type
Interventional
International Sponsor
N/A
Join our newsletter
"
*
" indicates required fields
Comments
This field is for validation purposes and should be left unchanged.
Full Name
*
Email
*